Treatment of Renal Stone with an Ayurvedic Drug (Kadali Kshara)

Efficacy of Kadali Kshara in Different Doses in the Management of Mootrashmari w s r to Urolithiasis A Randomised Double Blind Controlled Clinical Trial

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/09/027885

Enrollment

Registered

2020-09-18

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N22- Calculus of urinary tract in diseases classified elsewhere

Interventions

Intervention1: Kadali Kshara 250 mg: Dose one capsule Frequency twice daily Duration 28 days Route Of administration orally Control Intervention1: Kadali Kshara 500 mg: Dose one capsule Frequency twic

Eligibility

Inclusion criteria

Inclusion criteria: Non obstructive urolithiasis

Exclusion criteria

Exclusion criteria: Patients having any history of HTN DM BPH Ca of Prostate Hydronephrosis Renal failure HbSAg HIV 1 2 Any systemic disorder

Design outcomes

Primary

Measure	Time frame
size of stoneTimepoint: 7th day, 14th day and 28th day	—

Secondary

Measure	Time frame
How much size of stone reducedTimepoint: 28th day	—

Countries

India

Contacts

Public Contactkirthi A

KLE Shri BMK Ayurved Mahavidyalaya Belagavi

shalyalsd@gmail.com9480007651

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026